Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry

Published:2020-02-12 Issue:6 Volume:125 Page:827-835
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Viktorin-Baier Pascal¹²^ORCID,Putora Paul M.³⁴,Schmid Hans-Peter¹,Plasswilm Ludwig³⁴,Schwab Christoph¹,Thoeni Armin⁵,Hochreiter Werner⁶,Prikler Ladislav⁷,Suter Stefan⁸,Stucki Patrick²,Müntener Michael⁹,Blick Nadja⁹,Schiefer Hans³,Güsewell Sabine¹⁰,Zürn Karin¹,Engeler Daniel¹

Affiliation:

1. Department of Urology; St. Gallen Cantonal Hospital; St. Gallen Switzerland

2. Urology Clinic; Cantonal Hospital Lucerne; Lucerne Switzerland

3. Department of Radiation Oncology; St. Gallen Cantonal Hospital; St. Gallen Switzerland

4. Department of Radiation Oncology; University of Berne; Berne Switzerland

5. Clinic for Radiation-Oncology; Lindenhof Hospital Berne; Berne Switzerland

6. Urology Clinic; Hirslanden Clinic Aarau; Aarau Switzerland

7. Urology Clinic; Uroviva Clinic Buelach; Buelach Switzerland

8. Urology Clinic Zug; Zug Switzerland

9. Urology Clinic; Triemli Hospital; Zurich Switzerland

10. Clinical Trial Unit; St. Gallen Cantonal Hospital; St. Gallen Switzerland

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.15003/fullpdf

Reference29 articles.

1. Guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2017

2. American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy;Davis;Brachytherapy,2012

3. Low-dose-rate brachytherapy for prostate cancer: outcomes at >10 years of follow-up;Lazarev;BJU Int,2018

4. Long-term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low-dose-rate brachytherapy for localised prostate cancer;Langley;BJU Int,2018

5. Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience;Sylvester;Int J Radiat Oncol Biol Phys,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brachytherapy for favorable prognostic prostate cancer in men up to 60 years of age: Long term follow-up;Brachytherapy;2024-05

2. Langzeitauswertung der Low-dose-rate(LDR)-Brachytherapie des lokal begrenzten Prostatakarzinoms;Die Urologie;2023-05-31

3. Permanent LDR prostate brachytherapy: Comprehensive characterization of seed-dynamics within the prostate on a seed-only level;Brachytherapy;2022-09

4. Late genitourinary and gastrointestinal toxicity and radiation-induced second primary cancers in patients treated with low-dose-rate brachytherapy;Brachytherapy;2022-09

5. Acute and late side-effects after low dose-rate brachytherapy for prostate cancer; incidence, management and technical considerations;Brachytherapy;2021-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3